SpecStream

Data / Form D filings / Renue Life Sciences, Inc.

Renue Life Sciences, Inc.: Form D filing

Renue Life Sciences, Inc., a biotechnology company in San Carlos, CA, filed a Form D with the SEC in 2026. The latest, on October 14, 2026, reports $250,000 sold of a $3 million offering to 8 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Get filings like this oneWeekly RSS feed

Company details from the filing

Address
1030 BRITTAN AVE. ROOM 257, San Carlos, CA, 94070
Phone
(732) 692-3259
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2026
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2158207

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Oct 14New notice$3,000,000$250,000$2,750,0008Oct 2sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Samuel David PerliExecutive Officer, Director, Promoter
Phanidhar KukutlaExecutive Officer, Director, Promoter
Jean-Louis LelogeaisDirector

Other biotechnology companies in California that filed recently

Every Form D from the week of Oct 12 · All recent filings in California · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Renue Life Sciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.